Austrália - inglês - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - dexmedetomidine hydrochloride, quantity: 236 microgram (equivalent: dexmedetomidine, qty microgram) - injection, concentrated - excipient ingredients: sodium chloride; water for injections - icu sedation: for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine fresenius by continuous infusion in these patients should not exceed 24 hours. procedural sedation: for sedation of non-intubated patients prior to and/or during surgical and other procedures.

União Europeia - inglês - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - bortezomib - multiple myeloma - antineoplastic agents - bortezomib as monotherapy or in combination with pegylated liposomal doxorubicin or dexamethasone is indicated for the treatment of adult patients with progressive multiple myeloma who have received at least 1 prior therapy and who have already undergone or are unsuitable for haematopoietic stem cell transplantation.bortezomib in combination with melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for high-dose chemotherapy with haematopoietic stem cell transplantation.bortezomib in combination with dexamethasone, or with dexamethasone and thalidomide, is indicated for the induction treatment of adult patients with previously untreated multiple myeloma who are eligible for high-dose chemotherapy with haematopoietic stem cell transplantation.bortezomib in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.

Zimbábue - inglês - Medicines Control Authority

fresenius kabi south africa (pty) ltd - propofol - emulsions; injectable - 10mg/ml

Cingapura - inglês - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - intended for performing chronic and acute hemodialysis. it can be used in home dialysis, hemodialysis and limited care centres and clinical hemodialysis.

Cingapura - inglês - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - intended for performing chronic and acute hemodialysis. it can be used in home dialysis, hemodialysis and limited care centres and clinical hemodialysis.

Cingapura - inglês - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - intended for performing chronic and acute hemodialysis. it can be used in home dialysis, hemodialysis and limited care centres and clinical hemodialysis.

Cingapura - inglês - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - general hospital - the device is a peristaltic pump dedicated to enteral feeding. the pump is used to administrate to patient a volume of nutrition at a programmed flow rate. the pump is designed to administrate fluids through trans-nasal or percutaneous feeding tube.

Cingapura - inglês - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - gastroenterology & urology - the reverse osmosis system is an inhouse production unit for the production of permeate for use by dialysis devices and for the preparation of dialysis concentrates.

Cingapura - inglês - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - gastroenterology & urology - the aquabplus reverse osmosis system is an in-house production unit for the production of permeate for use by hemodialysis devices and for the preparation of dialysis concentrates.

Cingapura - inglês - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - gastroenterology & urology - the aquac reverse osmosis system, which can be cleaned using heat, is an in-house production unit for making permeate to be supplied directly to a hemodialysis device. a booster pump, a membrane module, and appropriate monitoring equipment (conductivity cell) are used to produce permeate from drinking water.